On April 26, Shanghai Huace Navigation Technology Ltd(300627) released the annual report of 2021. During the reporting period, the company achieved an operating revenue of 1.903 billion yuan, an increase of 35.02% over the same period of last year; The net profit attributable to shareholders of listed companies was 294 million yuan, an increase of 49.45% over the same period last year; The net profit after deducting non-profit was 230 million yuan, an increase of 53.17% over the same period of last year. Among them, the company’s foreign market achieved an operating revenue of 315 million yuan, a year-on-year increase of 59.31%; The Chinese market achieved an operating revenue of 1.588 billion yuan, a year-on-year increase of 31.05%. The company plans to distribute a cash dividend of 3.00 yuan (including tax) for every 10 shares to all shareholders and increase 4 shares for every 10 shares to all shareholders with capital reserve.
During the reporting period, the company’s R & D investment was 3327915 million yuan, an increase of 59.14% over the same period of last year, and the proportion of R & D investment in operating revenue was 17.49%, still maintaining a high growth level and proportion. In 2021, in addition to continuous investment in core technologies, the company invested in the research and development of a number of high-precision positioning and navigation intelligent equipment and solutions, such as visual RTK, new unmanned ships, agricultural machinery auto drive system, etc.
In 2022, the company will continue to increase strategic investment in research and development, continue to establish technical barriers in the aspects of high-precision satellite navigation basic devices such as chips, boards and modules, high-precision spatial three-dimensional data acquisition equipment, wide area enhanced service network construction (SWAs system) compatible with Beidou 3, and continuously improve the company’s core technical competitiveness. At the same time, the company’s Huaci spacetime intelligent innovation Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Park in Shanghai and Huaci spacetime Intelligent Science Innovation Park in Wuhan will be put into use in 2022, which will help the company make full use of the policies, business environment, talents and other resources of the two places, form complementary advantages, improve the company’s comprehensive operation ability and anti risk ability, and lay a foundation for the company’s long-term goal of sustained and effective growth.
The first quarter report released on the same day showed that the company’s revenue in a single quarter was 422 million yuan, a year-on-year increase of 21.97%; The net profit attributable to the parent company was 667262 million yuan, a year-on-year increase of 34.92%.
